Showing results (1-10 of 164) with videos related to
Sort By:
Pageof 17
Cell Cycle (Georgetown, Tex.)|February 7, 2009
Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapyAndrew Y Choo, John BlenisCancer Cell|February 14, 2006
TORgeting oncogene addiction for cancer therapyAndrew Y Choo, John BlenisMolecular Cell|November 25, 2010
ATM: Promoter of metabolic "cost" reduction and "savings" usage during hypoxia through mTORC1 regulationSang Gyun Kim, Andrew Y Choo, John BlenisCell|September 9, 2006
Mind the GAP: Wnt steps onto the mTORC1 trainAndrew Y Choo, Philippe P Roux, John BlenisProceedings of the National Academy of Sciences of the United States of America|October 29, 2008
Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translationAndrew Y Choo, Sang-Oh Yoon, Sang Gyun Kim, et al.Molecular Cell|June 2, 2010
Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supplyAndrew Y Choo, Sang Gyun Kim, Matthew G Vander Heiden, et al.Methods in Enzymology|June 8, 2006
Rheb activation of mTOR and S6K1 signalingJessie Hanrahan, John BlenisNature Reviews. Molecular Cell Biology|September 25, 2008
The RSK family of kinases: emerging roles in cellular signallingRana Anjum, John BlenisEndocrinology|April 2, 2022
Targeting mTOR in the Context of Diet and Whole-body MetabolismNikos Koundouros, John BlenisPageof 17